Your browser doesn't support javascript.
loading
Candidate mechanisms of acquired resistance to first-line osimertinib in EGFR-mutated advanced non-small cell lung cancer.
Chmielecki, Juliann; Gray, Jhanelle E; Cheng, Ying; Ohe, Yuichiro; Imamura, Fumio; Cho, Byoung Chul; Lin, Meng-Chih; Majem, Margarita; Shah, Riyaz; Rukazenkov, Yuri; Todd, Alexander; Markovets, Aleksandra; Barrett, J Carl; Hartmaier, Ryan J; Ramalingam, Suresh S.
Afiliação
  • Chmielecki J; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.
  • Gray JE; Department of Thoracic Oncology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL, USA. Jhanelle.Gray@moffitt.org.
  • Cheng Y; Jilin Provincial Cancer Hospital, Changchun, China.
  • Ohe Y; Department of Thoracic Oncology, National Cancer Center Hospital, Tokyo, Japan.
  • Imamura F; Department of Thoracic Oncology, Osaka International Cancer Institute, Osaka, Japan.
  • Cho BC; Division of Medical Oncology, Department of Internal Medicine, Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, Republic of Korea.
  • Lin MC; Division of Pulmonary and Critical Care Medicine, Kaohsiung Chang Gung Memorial Hospital, Chang Gung University, Kaohsiung, Taiwan.
  • Majem M; Medical Oncology Department, Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.
  • Shah R; Kent Oncology Centre, Maidstone Hospital, Maidstone and Tunbridge Wells NHS Trust, Maidstone, UK.
  • Rukazenkov Y; Oncology R&D, AstraZeneca, Cambridge, UK.
  • Todd A; Oncology Biometrics, Oncology R&D, AstraZeneca, Cambridge, UK.
  • Markovets A; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.
  • Barrett JC; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.
  • Hartmaier RJ; Translational Medicine, Oncology R&D, AstraZeneca, Boston, MA, USA.
  • Ramalingam SS; Winship Cancer Institute, Emory University, Atlanta, GA, USA.
Nat Commun ; 14(1): 1070, 2023 02 27.
Article em En | MEDLINE | ID: mdl-36849494

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Carcinoma Pulmonar de Células não Pequenas / Neoplasias Pulmonares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos